IQVIA reports second-quarter revenue up 8.7%
Revenue reached $4.368 billion, with adjusted EBITDA up 9.2% and raised full-year guidance.
See the latest news and media coverage for IQVIA. We track all announcements, press releases, and industry mentions in real time, all in one place.
Life sciences data, analytics, and clinical research company
iqvia.comLast updated
In short: IQVIA delivered strong financial growth in 2026, raising its profit guidance after reporting quarterly revenues exceeding $4.3 billion.
Revenue reached $4.368 billion, with adjusted EBITDA up 9.2% and raised full-year guidance.
Dr. Cynthia Verst testified before a House subcommittee, highlighting opportunities to modernize early clinical development while maintaining FDA standards.
The company will host a conference call and webcast at 9:00 a.m. ET, and the earnings release will be posted on the IR website.
The FDA recognized the partnership for enabling a diagnostic labeling expansion using real-world evidence.
The Dow rose 1.03% while the Nasdaq fell 0.22%, with IQVIA Holdings surging 14% and Amkor Technology plummeting 25%.
CEO & Chairman Ari Bousbib said, "IQVIA delivered an outstanding second quarter with revenue, adjusted EBITDA and adjusted diluted earnings per share, all exceeding the...
Here are some of the companies making headlines in midday trading. Boeing — Shares of the aerospace giant gained about 5% after second-quarter revenues narrowly...
Shares of clinical research company IQVIA (NYSE: IQV) jumped 12.9% in the morning session after the company reported second-quarter results that surpassed Wall Street's expectations...
Track IQVIA and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.